Ganga Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Ganga Pharmaceuticals has a total shareholder equity of ₹54.7M and total debt of ₹17.3M, which brings its debt-to-equity ratio to 31.7%. Its total assets and total liabilities are ₹78.0M and ₹23.3M respectively.
Key information
31.7%
Debt to equity ratio
₹17.33m
Debt
Interest coverage ratio | n/a |
Cash | ₹199.00k |
Equity | ₹54.66m |
Total liabilities | ₹23.33m |
Total assets | ₹77.99m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 539680's short term assets (₹56.4M) exceed its short term liabilities (₹16.0M).
Long Term Liabilities: 539680's short term assets (₹56.4M) exceed its long term liabilities (₹7.3M).
Debt to Equity History and Analysis
Debt Level: 539680's net debt to equity ratio (31.3%) is considered satisfactory.
Reducing Debt: 539680's debt to equity ratio has reduced from 40.6% to 31.7% over the past 5 years.
Debt Coverage: 539680's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 539680's interest payments on its debt are well covered by EBIT.